The Discounted Cash Flow (DCF) valuation of Mersana Therapeutics Inc (MRSN) is (430.83) USD. With the latest stock price at 28.59 USD, the upside of Mersana Therapeutics Inc based on DCF is -1606.9%.
Based on the latest price of 28.59 USD and our DCF valuation, Mersana Therapeutics Inc (MRSN) is a sell. selling MRSN stocks now will result in a potential gain of 1606.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.8% - 9.2% | 7.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (1,727.67) - (252.59) | (430.83) |
| Upside | -6142.9% - -983.5% | -1606.9% |